Manulife (Manufacturers Life Insurance)
REGN icon

Manulife (Manufacturers Life Insurance)’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$199M Sell
379,537
-18,699
-5% -$9.82M 0.18% 119
2025
Q1
$253M Buy
398,236
+41,826
+12% +$26.5M 0.24% 97
2024
Q4
$254M Buy
356,410
+18,366
+5% +$13.1M 0.22% 96
2024
Q3
$355M Sell
338,044
-2,522
-0.7% -$2.65M 0.31% 65
2024
Q2
$358M Buy
340,566
+2,270
+0.7% +$2.39M 0.33% 62
2024
Q1
$326M Sell
338,296
-1,364
-0.4% -$1.31M 0.3% 72
2023
Q4
$298M Sell
339,660
-26,314
-7% -$23.1M 0.18% 97
2023
Q3
$301M Buy
365,974
+1,474
+0.4% +$1.21M 0.18% 96
2023
Q2
$262M Buy
364,500
+13,635
+4% +$9.8M 0.15% 116
2023
Q1
$288M Buy
350,865
+5,454
+2% +$4.48M 0.16% 107
2022
Q4
$249M Buy
345,411
+80,532
+30% +$58.1M 0.16% 110
2022
Q3
$183M Buy
264,879
+8,379
+3% +$5.78M 0.13% 126
2022
Q2
$152M Buy
256,500
+5,757
+2% +$3.41M 0.11% 150
2022
Q1
$175M Buy
250,743
+49,658
+25% +$34.6M 0.11% 146
2021
Q4
$128K Buy
201,085
+5,969
+3% +$3.8K 0.08% 199
2021
Q3
$118M Buy
195,116
+93,097
+91% +$56.3M 0.1% 212
2021
Q2
$57M Sell
102,019
-1,706
-2% -$953K 0.05% 343
2021
Q1
$49.1M Buy
103,725
+7,217
+7% +$3.41M 0.04% 374
2020
Q4
$46.6M Sell
96,508
-1,942
-2% -$938K 0.04% 353
2020
Q3
$55.1M Sell
98,450
-9,529
-9% -$5.33M 0.06% 303
2020
Q2
$66M Buy
107,979
+20,395
+23% +$12.5M 0.06% 274
2020
Q1
$42.8M Buy
87,584
+11,886
+16% +$5.8M 0.05% 317
2019
Q4
$28.4M Sell
75,698
-2,110
-3% -$792K 0.03% 457
2019
Q3
$21.3M Buy
77,808
+2,942
+4% +$805K 0.02% 537
2019
Q2
$23.4M Sell
74,866
-6,060
-7% -$1.9M 0.03% 499
2019
Q1
$33.2M Buy
80,926
+2,549
+3% +$1.05M 0.04% 417
2018
Q4
$29.3M Sell
78,377
-1,741
-2% -$650K 0.04% 421
2018
Q3
$32.4M Sell
80,118
-3,553
-4% -$1.44M 0.03% 429
2018
Q2
$28.9M Buy
83,671
+7,410
+10% +$2.56M 0.03% 483
2018
Q1
$26.3M Sell
76,261
-4,592
-6% -$1.58M 0.03% 502
2017
Q4
$30.4M Sell
80,853
-5,432
-6% -$2.04M 0.03% 461
2017
Q3
$38.6M Buy
86,285
+1,308
+2% +$585K 0.05% 376
2017
Q2
$41.7M Buy
84,977
+1,037
+1% +$509K 0.05% 350
2017
Q1
$32.5M Buy
83,940
+4,207
+5% +$1.63M 0.04% 408
2016
Q4
$29.3M Buy
79,733
+3,692
+5% +$1.36M 0.04% 392
2016
Q3
$30.6M Buy
76,041
+598
+0.8% +$240K 0.05% 356
2016
Q2
$26.3M Buy
75,443
+2,594
+4% +$906K 0.04% 374
2016
Q1
$26.2M Sell
72,849
-6,644
-8% -$2.39M 0.02% 384
2015
Q4
$43.2K Sell
79,493
-1,585
-2% -$860 0.04% 270
2015
Q3
$37.7K Buy
81,078
+4,266
+6% +$1.98K 0.04% 303
2015
Q2
$39.2K Buy
76,812
+482
+0.6% +$246 0.05% 283
2015
Q1
$34.5K Sell
76,330
-2,492
-3% -$1.13K 0.04% 311
2014
Q4
$32.3K Buy
78,822
+2,968
+4% +$1.22K 0.05% 300
2014
Q3
$27.3K Sell
75,854
-6,503
-8% -$2.34K 0.04% 343
2014
Q2
$23.3M Buy
82,357
+3,578
+5% +$1.01M 0.04% 378
2014
Q1
$23.7K Buy
78,779
+1,727
+2% +$519 0.04% 383
2013
Q4
$21.2K Sell
77,052
-8,026
-9% -$2.21K 0.03% 402
2013
Q3
$26.6K Buy
85,078
+4,593
+6% +$1.44K 0.04% 327
2013
Q2
$18.1M Buy
+80,485
New +$18.1M 0.03% 392